The Centre for Infection and Immunity (Cii) is an exciting new initiative delivering high-quality research programmes to develop new treatments for infectious and inflammatory diseases. We are based in a newly built state of the art facility equipped with cutting edge technology and capacity for 200 researchers.
Cii is leading international programmes investigating the role innate and adaptive immune responses to infection and tissue injury and how these might be targeted to develop effective new treatments. Our research is primarily focused on lung diseases with major programmes in Asthma, Cystic Fibrosis, Lung infection and Acute Lung Injury. The Centre supports a highly interactive and collaborative, multidisciplinary environment between Molecular Immunologists, Microbiologists and Clinical researchers.
The Centre has a strong translational research emphasis, developing novel therapeutic strategies, using in vivo models of disease and conducting clinical trials including early phase programmes. This is supported by Northern Ireland CRN and international collaborations in Asthma, CF and early drug development. It also has strong links with industry partners in biotech and pharma.